The Non-Viral Drug Delivery Systems Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Non-Viral Drug Delivery Systems Market?
The market size for non-viral drug delivery systems has been expanding swiftly in the recent past. The market, which was valued at $8.6 billion in 2024, is projected to increase to $9.84 billion in 2025. This expansion signifies a compound annual growth rate (CAGR) of 14.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Non-Viral Drug Delivery Systems Industry?
The non-viral drug delivery systems market is projected to expand to $16.72 billion in 2029, with a compound annual growth rate (CAGR) of 14.2%.
Download Your Free Sample of the 2025 Non-Viral Drug Delivery Systems Market Report and Uncover Key Trends Now!
Global Market Segmentation: Identifying Major Non-Viral Drug Delivery Systems Industry Segments
The non-viral drug delivery systems market covered in this report is segmented –
1) By Type Of Molecule Delivered: Biologics, Small Molecules
2) By Type Of Biologics Delivered: Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA), Proteins or Peptides, Antibodies
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Development And Manufacturing Organizations (CDMOs), Hospitals And Clinics
What are the Key Growth Drivers Fueling the Non-Viral Drug Delivery Systems Market?
The key drivers in the non-viral drug delivery systems marketare:
• Rising adoption of targeted therapies
• Increasing investment in drug delivery research
• Growing preference for non-invasive treatments
• Rising integration of artificial intelligence and demand for sustained-release formulations
Pre-order the 2025 Non-Viral Drug Delivery Systems Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Non-Viral Drug Delivery Systems Market?
The key trends in the non-viral drug delivery systems market are:
• The advancement in nanocarrier technology is a key emerging trend.
• There is increasing innovation in mRNA delivery platforms.
• The integration of smart drug delivery devices is shaping the future of the market.
• Advanced gene editing delivery methods are a significant growing trend.
Who Are the Top Competitors & Leading Players in the Non-Viral Drug Delivery Systems Market?
Major companies in the non-viral drug delivery systems market are:
• Evonik Industries AG
• Cytiva
• Arcturus Therapeutics Holdings Inc.
• CureVac N.V.
• PolyPid Ltd
• Ethris GmbH
• Entos Pharmaceuticals Inc.
• Liquidia Technologies Inc.
• ReCode Therapeutics Inc.
• Enable Injections Inc.
• GenEdit Inc.
• N4 Pharma Plc
• Hopewell Therapeutics Inc.
• Tiba Biotech LLC
• Vesigen Therapeutics Inc.
• Carmine Therapeutics Inc.
• Evox Therapeutics Ltd
• InnoCore Pharmaceuticals BV
• Nanomerics Ltd
• DelSiTech Ltd
• Curapath Inc.
Regional Dominance: Which Area Leads the Global Non-Viral Drug Delivery Systems Market?
North America was the largest region in the non-viral drug delivery systems market in 2024
